Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation | Leukemia
Three-year probability of overall survival (OS), disease-free survival... | Download Scientific Diagram
A, Overall survival (OS) in patients who received 10‐day decitabine... | Download Scientific Diagram
Overall survival (OS) and relative survival by treatment intensity and... | Download Scientific Diagram
Treatment of Patients with Adult T Cell Leukemia/Lymphoma with Cord Blood Transplantation: A Japanese Nationwide Retrospective Survey - Biology of Blood and Marrow Transplantation
Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation | Bone Marrow Transplantation
Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC—an Update From the PACIFIC Trial - ScienceDirect
Overall survival (OS) amongst patients with AL amyloidosis undergoing... | Download Scientific Diagram
Overall survival (OS) of all patients (n = 3,011) according to age... | Download Scientific Diagram
Overall survival and progression-free survival based on high-dose... | Download Scientific Diagram
Impact of subsequent immune checkpoint inhibitor treatment on overall survival with avelumab vs docetaxel in platinum-treated advanced NSCLC: Post hoc analyses from the phase 3 JAVELIN Lung 200 trial - Lung Cancer
Very Young Children Who Undergo Hematopoietic Cell Transplantation at Weight Extremes Have Inferior Overall Survival and Increased Transplant Related Morality - Biology of Blood and Marrow Transplantation
OS, EFS, Relapse and NRM a Overall Survival (Kaplan-Meïer curves) for... | Download Scientific Diagram
Frontiers | Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study
Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis - Annals of Oncology
Frontiers | Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation
Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years - Biology of Blood and Marrow Transplantation
Prognostic benefit of stromal and epithelial CD8CD103 TRM infiltration... | Download Scientific Diagram
A, Overall survival (OS) in patients who received 10‐day decitabine... | Download Scientific Diagram